Related Experiment Video
Updated: Sep 2, 2025

07:44
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
1.3K
Construction of single-injection vaccine using new time-controlled release system
Haozheng Wang1, Lei Cui1, Ying Luo2
1Key Laboratory of Functional Polymer Materials and State Key Laboratory of Medicinal Chemical Biology, Institute of Polymer Chemistry, College of Chemistry, Nankai University, Tianjin 300071, China.
Biomaterials Advances
|August 5, 2022
Summary
A novel single-injection vaccine utilizes dynamic layer-by-layer (LBL) film technology for controlled antigen release, mimicking multi-dose schedules. This innovative vaccine enhances immune responses and improves patient compliance, offering better therapeutic outcomes.
Area of Science:
- Biomaterials Science
- Vaccinology
- Drug Delivery Systems
Background:
- Current multi-dose vaccination regimens face challenges including high cost and poor patient compliance.
- Achieving time-controlled release for single-injection vaccines has been a significant hurdle due to difficulties in controlling release kinetics.
Purpose of the Study:
- To develop a novel single-injection vaccine system capable of time-controlled antigen release.
- To design a vaccine that mimics the pulsatile release profile of conventional multi-dose vaccines.
- To evaluate the efficacy of this new vaccine in eliciting immune responses and inhibiting tumor growth.
Main Methods:
- Development of a single-injection vaccine utilizing dynamic layer-by-layer (LBL) film as an erodible coating.
- Utilizing the constant disintegration rate of dynamic LBL films for predictable, pulsatile antigen release.
- Assessing humoral and cellular immune responses and tumor growth inhibition in preclinical models.
Main Results:
- The dynamic LBL film demonstrated a constant disintegration rate, enabling distinct pulsatile antigen release at predetermined intervals.
- The single-injection vaccine's release pattern closely mimicked conventional multi-dose vaccination schedules.
- The vaccine elicited humoral and cellular immune responses comparable to or stronger than multi-dose regimes and showed enhanced tumor growth inhibition.
Conclusions:
- The developed dynamic LBL film technology offers a viable solution for creating effective single-injection vaccines with time-controlled release.
- This innovative vaccine approach promises to improve patient compliance and enhance therapeutic outcomes in vaccination.
- The system's ability to elicit robust immune responses and inhibit tumor growth highlights its potential clinical significance.

